RXi Pharmaceuticals to Webcast Investor Event on October 5, 2009

WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it will webcast its Second Annual Investor Event being held Monday, October 5, 2009 at 8:30 a.m. ET in New York City. The event will feature presentations by the Company’s senior management team including:

Back to news